Vanberra Signal
Free trial

Arbor Biotechnologies

Curated by Signal

Provider of genomic technologies and drug discovery platform

Life Sciences Technologyarbor.bio

Overview

Provider of genomic technologies and drug discovery platform. This platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening for enabling the discovery of proteins. The company has also identified a new CRISPR enzyme using its discovery platform.

Key facts

Founded
2016
Headquarters
Cambridge, United States
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

3 products and services
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Genesist

    Developer of CRISPR-based therapies to stop cancer metastasis and recurrence

    Life Sciences TechnologyFarmington, United States

  • Elepho

    Internet first brand offering multi-category baby health monitoring devices

    Life Sciences TechnologySimi Valley, United States

About Arbor Biotechnologies

What does Arbor Biotechnologies do?

Provider of genomic technologies and drug discovery platform.

Where is Arbor Biotechnologies headquartered?

Arbor Biotechnologies is headquartered in Cambridge, United States.

When was Arbor Biotechnologies founded?

Arbor Biotechnologies was founded in 2016.

Which sector is Arbor Biotechnologies in?

Arbor Biotechnologies operates in Life Sciences Technology.

Who are Arbor Biotechnologies's competitors?

Companies similar to Arbor Biotechnologies include Genesist, BioNumerik Pharmaceuticals, and Elepho.